Expanded Use of Surfactant Therapy in Newborns

• Autores: Thierry Lacaze-Masmonteil
• Localización: Clinics in Perinatology, ISSN 0095-5108, Vol. 34, Nº. 1, 2007, págs. 179-189
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Although there is no doubt that administration of exogenous surfactant to very preterm babies who have respiratory distress syndrome is safe and efficacious, surfactant inactivation or deficiency plays a role in the pathophysiology of other pulmonary disorders affecting newborn infants. Preliminary data suggest that there may be a role for surfactant administration to babies who have meconium aspiration syndrome, pneumonia, and possibly bronchopulmonary dysplasia. Further investigation is necessary but seems warranted.